Targeting DKK1 in Cancer

Time: 2:10 pm
day: Day Two

Details:

• Justifying the mechanistic rationale for neutralizing DKK1 in oncology
• Delving into the development of a DKK1 RNAscope biomarker assay
• Sharing results from their DisTinGuish clinical trial

Speakers: